Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
26.03
-0.17 (-0.65%)
Jul 16, 2025, 2:45 PM CST

Vcanbio Cell & Gene Engineering Corp., Company Description

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell detection tests in the People’s Republic of China.

The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells.

It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, genetic testing for drug safety guidance, disease genetic testing, and disease susceptibility testing for children and adults; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products.

In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and synthetic agents; and in vitro diagnostic reagents and medical devices.

The company was founded in 1992 and is based in Tianjin, the People’s Republic of China.

Vcanbio Cell & Gene Engineering Corp., Ltd
CountryChina
Founded1992
IndustryBiotechnology
SectorHealthcare
Employees2,014
CEOHongqi Wang

Contact Details

Address:
Huayuan Industrial Zone
Tianjin, 300384
China
Phone86 22 5877 5766
Websitevcanbio.com

Stock Details

Ticker Symbol600645
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE000000545
SIC Code2836

Key Executives

NamePosition
Hongqi WangVice Chairman and GM
Yi Qing ChenDeputy GM, Chief Financial Officer and Secretary
Hong Xiang ShiDeputy General Manager
Yu ZhangR&D Director
Dr. Huang JiaxueChief Technical Quality Officer
Yueming WangChief Human Resources Officer